they can't CR for ph3 , its $100m + investment. Maybe $200m-300m. ivx can't raise 0.5m to start it off with no backing.
they would only CR to buy more time to negotiate. That would be a hard sell, with no news. CEO still drawing his 200,000+ salary, shareholders gave him a payrise in 2013 I think. So I would want the management to cut their salaries if that was the case (maybe for options). Management's personal loans fall due in June/July from memory. If they extend that line of credit that would be good too. This points however to major crunch time in the next 4 weeks.
A little wild card now is the NIH study results too... could come from left field.
Invion will prevail, page-23
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.63M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $52 | 25.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 18960194 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 8596664 | 48 |
View Market Depth
| Last trade - 10.33am 12/11/2024 (20 minute delay) ? |
| IVX (ASX) Chart |